Tilbroquinol

Tilbroquinol is a medication used to treat amoebiasis, a parasitic infection caused by the amoeba Entamoeba histolytica. It is not commonly used in the United States, but is more frequently used in other countries, particularly in Asia.

Mechanism of action

Tilbroquinol works by inhibiting the growth of the amoeba Entamoeba histolytica, thereby preventing it from causing infection. The exact mechanism of action is not fully understood, but it is believed to involve disruption of the amoeba's cellular processes.

Uses

Tilbroquinol is primarily used to treat amoebiasis, but it may also be used to treat other parasitic infections. It is not a first-line treatment, but may be used when other treatments are ineffective or contraindicated.

Side effects

Common side effects of tilbroquinol include nausea, vomiting, and abdominal pain. Less common side effects may include headache, dizziness, and skin rash. Severe side effects are rare, but may include severe allergic reactions.

Contraindications

Tilbroquinol should not be used in individuals with a known hypersensitivity to the drug. It should also be used with caution in individuals with liver or kidney disease, as these conditions may affect the body's ability to metabolize and eliminate the drug.

Interactions

Tilbroquinol may interact with other medications, including other antiparasitic drugs. It is important to inform your healthcare provider of all medications you are currently taking to avoid potential interactions.

See also

• Amoebiasis
• Entamoeba histolytica
• Antiparasitic drugs

Tilbroquinol Resources
Latest articles Most recent articles Ongoing trials	Wikipedia